PT
Parabolica Therapeutics, Inc.
SEC filingBiotechnology · Dallas, TX
Amount raised$50Ksold at filing
Total offering$250K$200K still open
Investors in the raise2count reported to the SEC
FiledApr 30, 2026first sale Mar 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brian J. BrilleDirector
Andrew WangExecutive Officer, Director
Narendra ChokshiExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.